Registry of Deep Brain Stimulation With the VERCISEâ„¢ System: Vercise DBS Registry
Registry of Deep Brain Stimulation With the VERCISEâ„¢ System: Vercise DBS Registry
The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease.
The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated.
Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.
The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS system in the treatment of Parkinson's disease.
Subjects' improvement in disease symptoms and overall Quality of life will be assessed during the study following DBS and compared with baseline. Additionally, the utilization of Image Guided Programming (IGP) when used as a planning tool for programming of patients is also evaluated.
Key Inclusion Criteria:
Key Exclusion Criteria:
Subjects with significant cognitive or psychiatric impairment may be excluded in the evaluation of GXT.
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
Los Angeles, California 90048, United States
BSNClinicalTrials@bsci.com855-213-9890
Winston-Salem, North Carolina 27157, United States
San Antonio, Texas 78229, United States
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890